Angelini Pharma and INCIPIT, Italian Network for Paediatric Clinical Trials sharing the scope to promote high quality research on drugs, are now
launching the first edition of call for proposals - Angelini for Future 2021- to support independent research
projects proposed by European investigators working in public or private non-profit healthcare organizations.
In this joint collaboration, Angelini allocates 300 K€ to fund up to two research projects either in late
preclinical phase or in early clinical phase and INCIPIT provides the expertise to prepare the call, to manage
the evaluation process of the research projects and to perform monitoring of the scientific results.
Key dates and deadlines:
- Opening date: January 29th 2021. Information and application forms will be available upon request to [email protected]
- Closing date: March 31st 2021 at 5 pm. Complete applications must be received at
- [email protected] email address by March 31st 2021 at 5 pm.
- Evaluation: April-May 2021. During this period applications will be reviewed and selected.
- Award: May 2021. Selected applicants will receive notification letter
For futher information, please download the Call for proposal and visit the Incipit website.
